Universität zu Köln

Gluz, Oleg, Kolberg-Liedtke, Cornelia, Marme, Frederik and Thill, Marc (2020). Use of Taxanes in Metastatic HER2-negative Breast Cancer - a Status Report. Geburtshilfe Frauenheilkd., 80 (4). S. 399 - 410. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804

Full text not available from this repository.

Abstract

The most important goal of treatment of patients with metastatic breast cancer is maintenance or even improvement of quality of life. In this setting, chemotherapy should be used with as much restraint as possible. If palliative chemotherapy is indicated, the taxane drug class is an established treatment option. The updated guidelines of the Gynaecological Oncology Working Group (AGO), Breast Committee, of the German Society for Gynaecology and Obstetrics (DGGG) and the German Cancer Society e.V. (DKG) provide recommendations with the greatest possible evidence on which of the licensed taxanes can be used in which treatment situation in the metastatic setting.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Gluz, Oleg UNSPECIFIED UNSPECIFIED UNSPECIFIED Kolberg-Liedtke, Cornelia UNSPECIFIED UNSPECIFIED UNSPECIFIED Marme, Frederik UNSPECIFIED UNSPECIFIED UNSPECIFIED Thill, Marc UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-338471
DOI:	10.1055/a-1126-4247
Journal or Publication Title:	Geburtshilfe Frauenheilkd.
Volume:	80
Number:	4
Page Range:	S. 399 - 410
Date:	2020
Publisher:	GEORG THIEME VERLAG KG
Place of Publication:	STUTTGART
ISSN:	1438-8804
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language PHASE-III TRIAL; SOLVENT-BASED PACLITAXEL; INTERNATIONAL CONSENSUS GUIDELINES; WEEKLY NAB-PACLITAXEL; 1ST-LINE TREATMENT; FINAL ANALYSIS; FREE SURVIVAL; DOCETAXEL; CHEMOTHERAPY; COMBINATION Multiple languages Obstetrics & Gynecology Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/33847